| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.00094 | 1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.00072 | 1 |